Anti-Wnt3a antibody [3A6]
3
(2 Reviews)
|
(21 Publications)
Mouse Monoclonal WNT3A antibody. Suitable for WB and reacts with Human samples. Cited in 21 publications. Immunogen corresponding to Recombinant Full Length Protein corresponding to Human WNT3A.
View Alternative Names
Protein Wnt-3a, WNT3A
- WB
Unknown
Western blot - Anti-Wnt3a antibody [3A6] (AB81614)
All lanes:
Western blot - Anti-Wnt3a antibody [3A6] (ab81614) at 1/1000 dilution
Lane 1:
293T cell lysate at 40 µg
Lane 2:
Wnt3a transfected 293T cell lysate at 40 µg
Secondary
All lanes:
goat anti-mouse secondary antibody conjugated to HRP
Predicted band size: 39 kDa
false
Reactivity data
Product details
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Wnt3a plays a critical role in embryonic development and cell proliferation. As part of a larger complex it partners with other signaling molecules to ensure proper cellular communication. Wnt3a is important in patterning during embryogenesis influencing processes like axis formation and organogenesis. Its expression impacts the development of skeletal structures by regulating the differentiation and proliferation of precursor cells.
Pathways
Wnt3a is an integral component of the canonical Wnt/β-catenin signaling pathway which regulates gene expression essential for cell fate decisions. This pathway is activated when Wnt3a binds to the Frizzled and LRP5/6 receptor complex stabilizing β-catenin in the cytosol. Glycogen synthase kinase 3 beta (GSK-3β) and Adenomatosis polyposis coli (APC) are key proteins involved which help mediate the signal to downstream targets involved in cell growth and development.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (21)
Recent publications for all applications. Explore the full list and refine your search
Cancer management and research 17:1989-1997 PubMed41019940
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 14:27053 PubMed39511359
2024
Applications
Unspecified application
Species
Unspecified reactive species
Bioengineered 13:3070-3081 PubMed35100096
2022
Applications
Unspecified application
Species
Unspecified reactive species
Molecular therapy. Nucleic acids 26:1318-1335 PubMed34853730
2021
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 12:362 PubMed33441552
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cardiovascular medicine 7:567837 PubMed33330641
2020
Applications
Unspecified application
Species
Unspecified reactive species
Cell cycle (Georgetown, Tex.) 19:3231-3248 PubMed33198579
2020
Applications
Unspecified application
Species
Unspecified reactive species
Molecular oncology 14:462-483 PubMed31785055
2019
Applications
Unspecified application
Species
Unspecified reactive species
Cell communication and signaling : CCS 17:109 PubMed31462314
2019
Applications
Unspecified application
Species
Unspecified reactive species
Oncology reports 41:3137-3147 PubMed30896857
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com